COCP

1.13

1.74% -0.02

Handel nachbörslich: 1.12 -0.010 -0.88%

Cocrystal Pharma Inc (COCP)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.15

Offen:

$1.26

24-Stunden-Volumen:

348.45K

Relative Volume:

0.15

Marktkapitalisierung:

$15.58M

Einnahmen:

Nettoeinkommen (Verlust:

$-8.83M

KGV:

-1.4293

EPS:

-0.7906

Netto-Cashflow:

$-8.61M

1W Leistung:

-1.74%

1M Leistung:

-20.98%

6M Leistung:

+11.88%

1J Leistung:

-22.60%

1-Tages-Spanne:

$1.13

$1.26

1-Wochen-Bereich:

$1.08

$1.26

52-Wochen-Spanne:

$0.8588

$2.67

Cocrystal Pharma Inc Stock (COCP) Company Profile

Firmenname

Cocrystal Pharma Inc

Sektor

Healthcare (1111)

Branche

Biotechnology (621)

Telefon

(786) 459-1831

Adresse

19805 N. CREEK PARKWAY, BOTHELL, WA

Mitarbeiter

Twitter

@cocrystalpharma

Nächster Verdiensttermin

2026-05-21

Neueste SEC-Einreichungen

COCP's Discussions on Twitter

Compare COCP vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
COCP Cocrystal Pharma Inc	1.13	15.86M	0	-8.83M	-8.61M	-0.7906
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-07-08	Eingeleitet	H.C. Wainwright	Buy

Cocrystal Pharma Inc Aktie (COCP) Neueste Nachrichten

09:45 AM

Cocrystal Pharma (NASDAQ: COCP) highlights pan-viral inhibitor data and Phase 1b progress - Stock Titan

08:30 AM

08:00 AM

Deadly cruise ship hantavirus; Cocrystal runs lab tests on pan-viral blockers - Stock Titan

08:00 AM

May 21, 2026

Cocrystal Pharma Stock Slips: Why COCP’s Norovirus Bet Is Back in Focus - Bez Kabli

May 21, 2026

May 20, 2026

Cocrystal (COCP) Q1 2026 Earnings Miss by Significant: Key TakeawaysMargin Compression Risk - Newser

May 20, 2026

May 18, 2026

Why Is Cocrystal Pharma, Inc. (COCP) Stock Down Today? - Meyka

May 18, 2026

May 15, 2026

Cocrystal (COCP) Declines -3.57% Amid Market Weakness 2026-05-15Market Neutral Pair - newser.com

May 15, 2026

Cocrystal Pharma, Inc. 2026 Q1 Financials: Company Overview, Segment Information, and Going Concern Risks - Minichart

May 15, 2026

Cocrystal Pharma Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026

Cocrystal Pharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2026

Cocrystal Pharma, Inc. 1Q 2026: Net loss $(2.30M), No revenue — 10-Q Summary - TradingView

May 15, 2026

Cocrystal Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

[10-Q] Cocrystal Pharma, Inc. Quarterly Earnings Report - Stock Titan

May 15, 2026

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewswire

May 15, 2026

May 14, 2026

Number of shareholders of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView

May 14, 2026

May 13, 2026

Number of shareholders of Cocrystal Pharma Inc – LS:A3DWYX - TradingView

May 13, 2026

May 11, 2026

What Cocrystal (COCP) is building for next year | Q4 2025: EPS Exceeds ExpectationsSlow Growth - newser.com

May 11, 2026

Cocrystal Pharma Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

May 11, 2026

May 04, 2026

[EFFECT] Cocrystal Pharma, Inc. SEC Filing - Stock Titan

May 04, 2026

May 01, 2026

Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection - The Manila Times

May 01, 2026

Apr 30, 2026

Cocrystal Showcases Norovirus Candidate CDI-988 at ICAR 2026 - TipRanks

Apr 30, 2026

Cocrystal Pharma (COCP) advances Fast Track CDI-988 in Phase 1b norovirus challenge study - Stock Titan

Apr 30, 2026

No approved norovirus drugs; Cocrystal tests oral CDI-988 - Stock Titan

Apr 30, 2026

Apr 28, 2026

COCP stock soars 75% — what is the link to Cocrystal’s norovirus treatment? - MSN

Apr 28, 2026

Apr 23, 2026

Cocrystal Pharma Incfiles to offer up to $150 million in securitiesSEC filing - marketscreener.com

Apr 23, 2026

Cocrystal Pharma (NASDAQ: COCP) files $150M shelf to offer stock and warrants - Stock Titan

Apr 23, 2026

Apr 22, 2026

COCP: Q4 2025 Earnings: Cocrystal Pharma Inc. posts 4.8% EPS beat with no Q4 revenueTop Analyst Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Cocrystal (COCP) Stock: Why Efficiency Gains (Momentum Building) 2026-04-22RSI Oversold Stocks - Xã Vĩnh Công

Apr 22, 2026

Apr 17, 2026

Why Cocrystal Pharma Shares Are Cooling Off Monday? - MSN

Apr 17, 2026

Apr 16, 2026

Form 8-KCurrent report - ADVFN

Apr 16, 2026

Apr 15, 2026

Cocrystal Pharma (COCP) price target increased by 33.33% to 8.16 - MSN

Apr 15, 2026

Apr 13, 2026

Smart Money: Can Cocrystal Pharma Inc deliver consistent EPS growth2026 Technical Patterns & Daily Growth Stock Tips - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Investor Mood: Is Cocrystal Pharma Inc benefiting from innovation trendsQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Apr 10, 2026

What events could move Cocrystal (COCP) Stock next | Price at $1.29, Down 9.79%Factor Momentum - Newser

Apr 10, 2026

Apr 08, 2026

Tech Rally: Is Cocrystal Pharma Inc stock risky to hold nowMarket Activity Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention - Zacks Small Cap Research

Apr 07, 2026

Apr 05, 2026